 - Requirement of anticoagulant therapy with oral vitamin K antagonists such as Coumadin warfarin. Low-dose anticoagulants for the maintenance of patency in a central venous access device or the prevention of deep vein thrombosis or pulmonary embolism is allowed. Therapeutic use of low molecular weight heparin is allowed. 